Interference No. 104,241 1989). Jeon et al. elected to prove they were prima facie entitled to judgment by attempting to prove that they actually reduced to practice an embodiment within the count prior to Cupps et al.'s effective filing date. See page 4 of Paper Number 10 of Jeon et al.'s involved application ("REQUEST FOR INTERFERENCE UNDER 37 C.F.R. §1.607 AND SHOWING UNDER 37 C.F.R. §1.608(b)). The count in this interference is a so-called bifurcated count, that is, the count defines the interfering subject matter in four alternatives, each of which is presumed to be the "same patentable invention" in the sense of 37 C.F.R. § 1.601(n). Thus, the count requires: either of two compounds represented by a particular structural formula; a pharmaceutical composition comprising a safe and effective amount of a compound of either aforementioned formula; or, a method for preventing or treating various diseases comprising administering a safe and effective amount of a compound of either formula. Thus, the evidence relied on by Jeon et al. in their showing under the rule must establish that every limitation of 16Page: Previous 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 NextLast modified: November 3, 2007